Alcresta : Alcresta Therapeutics announces commercial availability of nextgeneration RELiZORB cartridge
Alcresta Therapeutics, Inc., a leading commercial─stage company focused on developing and commercializing novel enzyme─based products, announced the commercial availability of the next─generation RELiZORB
Read full article »
Alcresta is a Massachusetts-based pharmaceutical company that researches, develops, and markets novel enzyme-based products for the treatment of gastrointestinal disorders.
Read more